AAAAAA
Results:
1-20
|
Results: 20
Authors:
Sirota, P
Citation: P. Sirota, The 11th research day of Y. Abarbanel Mental Health Center Bat Yam and Sackler Faculty of Medicine - Wednesday, 28th June 200, Tel Aviv University, ISR J PSYCH, 38(1), 2001, pp. 69-69
Authors:
Hassin-Baer, S
Sirota, P
Korczyn, AD
Treves, TA
Epstein, B
Shabtai, H
Martin, T
Litvinjuk, Y
Giladi, N
Citation: S. Hassin-baer et al., Clinical characteristics of neuroleptic-induced parkinsonism, J NEURAL TR, 108(11), 2001, pp. 1299-1308
Authors:
Sirota, P
Epstein, B
Benatov, R
Sousnostzky, M
Kindler, S
Citation: P. Sirota et al., An open study of buspirone augmentation of neuroleptics in patients with schizophrenia, J CL PSYCH, 21(4), 2001, pp. 454-455
Authors:
Sirota, P
Mosheva, T
Shabtai, H
Korczyn, AD
Citation: P. Sirota et al., Treating tardive dyskinesia with ondansetron, J CL PSYCH, 21(3), 2001, pp. 355-356
Authors:
Barak, Y
Sirota, P
Kimhi, R
Slor, H
Citation: Y. Barak et al., Werner's syndrome (adult progeria): An affected mother and son presenting with resistant psychosis, COMP PSYCHI, 42(6), 2001, pp. 508-510
Authors:
Sirota, P
Giladi, N
Shabtai, H
Korczyn, AD
Citation: P. Sirota et al., Ondansetron for tardive dyskinesia - Dr. Sirota and colleagues reply, AM J PSYCHI, 158(4), 2001, pp. 658-658
Authors:
Sirota, P
Bogdanov, I
Citation: P. Sirota et I. Bogdanov, Priapism associated with risperidone treatment, INT J PSYC, 4(3), 2000, pp. 237-239
Authors:
Reznik, I
Benatov, R
Sirota, P
Citation: I. Reznik et al., Long-term efficacy and safety of quetiapine in treatment-refractory schizophrenia: A case report, INT J PSYC, 4(1), 2000, pp. 77-80
Authors:
Yovel, G
Sirota, P
Mazeh, D
Shakhar, G
Rosenne, E
Ben-Eliyahu, S
Citation: G. Yovel et al., Higher natural killer cell activity in schizophrenic patients: The impact of serum factors, medication, and smoking, BRAIN BEH, 14(3), 2000, pp. 153-169
Authors:
Rapaport, A
Sadeh, M
Stein, D
Levine, J
Sirota, P
Mosheva, T
Stir, S
Elitzur, A
Reznik, I
Geva, D
Rabey, JM
Citation: A. Rapaport et al., Botulinum toxin for the treatment of oro-facial-lingual-masticatory tardive dyskinesia, MOVEMENT D, 15(2), 2000, pp. 352-355
Authors:
Melamed, Y
Sirota, P
Citation: Y. Melamed et P. Sirota, Erythrocyte sedimentation rate in patients with schizophrenia, CAN J PSY, 45(10), 2000, pp. 938-938
Authors:
Reznik, I
Sirota, P
Citation: I. Reznik et P. Sirota, An open study of fluvoxamine augmentation of neuroleptics in schizophreniawith obsessive and compulsive symptoms, CLIN NEUROP, 23(3), 2000, pp. 157-160
Authors:
Reznik, I
Sirota, P
Citation: I. Reznik et P. Sirota, Obsessive and compulsive symptoms in schizophrenia: A randomized controlled trial with fluvoxamine and neuroleptics, J CL PSYCH, 20(4), 2000, pp. 410-416
Authors:
Yovel, G
Sirota, P
Mazeh, D
Shakhar, G
Rosenne, E
Ben-Eliyahu, S
Citation: G. Yovel et al., Higher natural killer cell activity in schizophrenic patients: The impact of serum factors, medication, and smoking, ADV DRUG DE, 42(3), 2000, pp. 153-169
Authors:
Rotenberg, VS
Indursky, P
Kayumov, L
Sirota, P
Melamed, Y
Citation: Vs. Rotenberg et al., The relationship between subjective sleep estimation and objective sleep variables in depressed patients, INT J PSYCP, 37(3), 2000, pp. 291-297
Authors:
Sirota, P
Mosheva, T
Shabtay, H
Giladi, N
Korczyn, AD
Citation: P. Sirota et al., Use of the selective serotonin 3 receptor antagonist ondansetron in the treatment of neuroleptic-induced tardive dyskinesia, AM J PSYCHI, 157(2), 2000, pp. 287-289
Authors:
Sirota, P
Davidson, B
Mosheva, T
Benhatov, R
Zohar, J
Gross-Isseroff, R
Citation: P. Sirota et al., Increased olfactory sensitivity in first episode psychosis and the effect of neuroleptic treatment on olfactory sensitivity in schizophrenia, PSYCHIAT R, 86(2), 1999, pp. 143-153
Authors:
Reznik, I
Benatov, R
Sirota, P
Citation: I. Reznik et al., Long-term efficacy and tolerability of quetiapine in treatment-refractory schizophrenia: A case study, J CLIN PSY, 60, 1999, pp. 16-16
Authors:
Reznik, I
Sirota, P
Citation: I. Reznik et P. Sirota, Premorbid social functioning with schizophrenia and bipolar disorder, AM J PSYCHI, 156(6), 1999, pp. 986-986
Authors:
Cohen, Y
Chetrit, A
Cohen, Y
Sirota, P
Modan, B
Citation: Y. Cohen et al., Cancer morbidity in psychiatric patients: influence of lithium carbonate treatment, MED ONCOL, 15(1), 1998, pp. 32-36
Risultati:
1-20
|